A detailed history of Forbes J M & CO LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Forbes J M & CO LLP holds 1,609 shares of LLY stock, worth $1.28 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,609
Previous 1,554 3.54%
Holding current value
$1.28 Million
Previous $1.41 Million 1.35%
% of portfolio
0.14%
Previous 0.15%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$772.14 - $960.02 $42,467 - $52,801
55 Added 3.54%
1,609 $1.43 Million
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $10,148 - $12,726
-14 Reduced 0.89%
1,554 $1.41 Million
Q1 2024

Apr 11, 2024

SELL
$592.2 - $792.28 $14,805 - $19,807
-25 Reduced 1.57%
1,568 $1.22 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $4,348 - $5,107
14 Added 0.89%
1,593 $547,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $10,611 - $12,364
-33 Reduced 2.05%
1,579 $578,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $296,480 - $337,870
-1,000 Reduced 38.28%
1,612 $521,000
Q2 2022

Jul 22, 2022

SELL
$278.73 - $327.27 $54,073 - $63,490
-194 Reduced 6.91%
2,612 $847,000
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $3,285 - $4,083
-14 Reduced 0.5%
2,806 $804,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $44,970 - $55,808
200 Added 7.63%
2,820 $779,000
Q2 2020

Aug 07, 2020

SELL
$136.42 - $164.18 $53,203 - $64,030
-390 Reduced 12.96%
2,620 $430,000
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $40,477 - $50,099
340 Added 12.73%
3,010 $419,000
Q4 2019

Feb 07, 2020

BUY
$106.92 - $132.43 $21,384 - $26,486
200 Added 8.1%
2,670 $351,000
Q3 2018

Nov 02, 2018

SELL
$85.86 - $107.31 $12,879 - $16,096
-150 Reduced 5.73%
2,470 $265,000
Q4 2017

Feb 09, 2018

SELL
$81.94 - $87.89 $16,388 - $17,578
-200 Reduced 7.09%
2,620 $221,000
Q2 2017

Aug 10, 2017

BUY
N/A
2,820
2,820 $232,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Forbes J M & CO LLP Portfolio

Follow Forbes J M & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forbes J M & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Forbes J M & CO LLP with notifications on news.